Most of the candidate genes of which we confirmed cancer-specific AS in NSCLC are also involved in these processes (ADD3, CLSTN1, FN1, MYO18A, NUMB, SYNE2, and TPM1). This evidence concerns the gene CLSTN1 and non-small cell lung carcinoma.